DJO Global has reported net sales of $286 million for the second quarter, representing a 2.9 percent increase over the same quarter last year. The company's net sales, when broken out, show net sales for the surgical implant segment were $18.1 million in the second quarter, reflecting an increase of 10.2 percent over net sales in the second quarter of 2011. Mike Mogul, DJO's president and chief executive officer, attributed the increased sales to strong sales of new products.
More Articles on Orthopedic Devices:
Study to Compare Benvenue Medical, Medtronic Spinal Systems
National Capital Region Medical Adopts HemaClear Device
Medtronic Receives 510(k) Approval for Orthopedic Sealer